These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics. Perez JG; Tran NL; Rosenblum MG; Schneider CS; Connolly NP; Kim AJ; Woodworth GF; Winkles JA Oncogene; 2016 Apr; 35(17):2145-55. PubMed ID: 26300004 [TBL] [Abstract][Full Text] [Related]
10. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention. Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193 [TBL] [Abstract][Full Text] [Related]
11. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis. Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367 [TBL] [Abstract][Full Text] [Related]
12. The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion. Cheng E; Whitsett TG; Tran NL; Winkles JA Mol Cancer Res; 2015 Mar; 13(3):575-83. PubMed ID: 25392346 [TBL] [Abstract][Full Text] [Related]
13. Endogenous RhoG is rapidly activated after epidermal growth factor stimulation through multiple guanine-nucleotide exchange factors. Samson T; Welch C; Monaghan-Benson E; Hahn KM; Burridge K Mol Biol Cell; 2010 May; 21(9):1629-42. PubMed ID: 20237158 [TBL] [Abstract][Full Text] [Related]
14. Tyrosine Phosphorylation of SGEF Regulates RhoG Activity and Cell Migration. Okuyama Y; Umeda K; Negishi M; Katoh H PLoS One; 2016; 11(7):e0159617. PubMed ID: 27437949 [TBL] [Abstract][Full Text] [Related]
16. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system. Echeverry R; Wu F; Haile WB; Wu J; Yepes M J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384 [TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death. Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770 [TBL] [Abstract][Full Text] [Related]
18. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization. Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972 [TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling. Cherry EM; Lee DW; Jung JU; Sitcheran R Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756 [TBL] [Abstract][Full Text] [Related]
20. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. Vince JE; Chau D; Callus B; Wong WW; Hawkins CJ; Schneider P; McKinlay M; Benetatos CA; Condon SM; Chunduru SK; Yeoh G; Brink R; Vaux DL; Silke J J Cell Biol; 2008 Jul; 182(1):171-84. PubMed ID: 18606850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]